Organ On A Chip Technology
The Quasi Vivo® system is an advanced interconnected cell culture flow system, engineered to provide in vivo like conditions for cell growth.
SAVING LIVES THROUGH BETTER SCIENCE™
Kirkstall Ltd. is a biotechnology company, operating within the global organ-on-a-chip market. Established in 2006, our aim is to satisfy the overwhelming need for more human relevant science, brought about by the failures of traditional in vitro research and animal research models.
Designed to eliminate bubbles and provide laminar flow. It allows for submerged cell culture, whilst the modular nature allows for interconnecting cell co-culture.
The QV600 chamber allows the creation of an air liquid interface or liquid/liquid barrier model through the insertion of commercially available inserts or transwells.
The QV900 6-chamber optical tray provides a compact, “organ-on-a-chip” like disposable unit making it ideal for users requiring high-content experiments and for industrial use.
“The utility of in vitro testing in toxicology and also to some extent in compound discovery activities has been very limited in the past. The Quasi Vivo® technology overcomes many of the major obstacles preventing in vitro techniques from being a scientifically valid approach that can mimic accurately what can happen in and between different human and animal tissues.”
Prof. David Tweats, former Vice-President of GSK
The Quasi Vivo® system is specifically designed for ease of use and adaptability.
There are 3 different chambers available, giving you a wide variety of applications, including but not limited to:
OUT AND ABOUT - SUMMER 2017 LET'S TALK FLOW With visits to existing and potential users lined up in June and July, as well as attending SPTC in Paris, TCES in Manchester, INEXO in Monpellier and AETOX in Valencia, the Kirkstall team will most likely be travelling to,...read more
WHY QUASI VIVO®? The number of Quasi Vivo® users is growing worldwide, with over 70 different labs in over 15 different countries now using our system for a variety of applications. We recently caught up with a handful of users to find out why they chose Quasi...read more
ACTC 2017 Proceedings Professors, Primary Investigators, Post Docs and PhD students.... ACTC was again a great success with researchers assembling from 9 different nations to discuss their research. For those unable to make ACTC 2017 we've now uploaded the conference...read more